octobre 21, 2025 - Page 12 sur 13

Psychotropic-associated delusional pseudo-gender dysphoria: a case report

Abdel Aziz K, Al Ammari AS, Alzaabi MS, Al Naqbi FJ, Adi MM, Aljaberi FS, Ouda ZH, Stip E. BMC Psychiatry. 2025 Oct 10;25(1):969. doi: 10.1186/s12888-025-07450-7. PMID: 41073994; PMCID: PMC12512310 CONSULTER

Psychotropic-associated delusional pseudo-gender dysphoria: a case report Lire la suite »

The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis

Publications / ICRIS Québec

Panagiotoglou D, Peterson S, Lavergne MR, Gomes T, Chadha R, Hawley P, McCracken R. CMAJ. 2025 May 11;197(18):E497-E505. doi: 10.1503/cmaj.250167. PMID: 40355138; PMCID: PMC12077321. CONSULTER

The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis Lire la suite »

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study

Publications / ICRIS Québec

Panagiotoglou D, Peterson S, Lavergne MR, Gomes T, Chadha R, Johnson C, McCracken R. Harm Reduct J. 2025 Jun 25;22(1):111. doi: 10.1186/s12954-025-01261-5. PMID: 40563109; PMCID: PMC12199528. CONSULTER

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study Lire la suite »

The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study

Publications / ICRIS Québec

Lim J, Bruneau J, Platt RW, Panagiotoglou D. Drug Saf. 2025 Nov;48(11):1271-1280. doi: 10.1007/s40264-025-01574-1. Epub 2025 Jul 3. PMID: 40608239 CONSULTER

The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study Lire la suite »

Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update

Publications / ICRIS Québec

Tatar O, Bakouni H, Abdel-Baki A, Jutras-Aswad D. Cannabis Cannabinoid Res. 2025 Feb;10(1):11-17. doi: 10.1089/can.2024.0094. Epub 2024 Oct 24. PMID: 39446673. CONSULTER

Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update Lire la suite »

Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis

Publications / ICRIS Québec

Bastien G, McAnulty C, Sharafi H, Mahroug A, Elkrief L, Ziegler D, Dubreucq S, Juteau LC, Jutras-Aswad D. J Addict Med. 2025 May-Jun 01;19(3):322-330. doi: 10.1097/ADM.0000000000001422. Epub 2024 Nov 26. PMID: 39591619 CONSULTER

Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis Lire la suite »

Cannabis legalization: a call for the integration of main health and crime indicator domains towards comprehensive policy impact assessments

Publications / ICRIS Québec

Fischer B, Robinson T, Jutras-Aswad D. J Public Health Policy. 2025 Jun;46(2):423-432. doi: 10.1057/s41271-025-00552-2. Epub 2025 Jan 19. PMID: 39828760 CONSULTER

Cannabis legalization: a call for the integration of main health and crime indicator domains towards comprehensive policy impact assessments Lire la suite »

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Publications / ICRIS Québec

Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D. Harm Reduct J. 2025 Feb 8;22(1):14. doi: 10.1186/s12954-025-01157-4. PMID: 39923043; PMCID: PMC11806552. CONSULTER

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study Lire la suite »

Commentary on Coelho et al.: Ecological momentary assessments may be key to the future of cannabis studies

Publications / ICRIS Québec

Chester L, Hebert FO, Jutras-Aswad D. Addiction. 2025 Jun;120(6):1182-1183. doi: 10.1111/add.70066. Epub 2025 Apr 3. PMID: 40177708; PMCID: PMC12046481 CONSULTER

Commentary on Coelho et al.: Ecological momentary assessments may be key to the future of cannabis studies Lire la suite »

A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study

Publications / ICRIS Québec

Bach P, Le Foll B, Davidson S, de Kiewit A, Bakouni H, Poulin G, Ghosh M, Jutras-Aswad D. Contemp Clin Trials. 2025 Jun;153:107916. doi: 10.1016/j.cct.2025.107916. Epub 2025 Apr 13. PMID: 40233849 CONSULTER

A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study Lire la suite »

21 octobre 2025

Psychotropic-associated delusional pseudo-gender dysphoria: a case report

The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study

The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study

Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update

Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis

Cannabis legalization: a call for the integration of main health and crime indicator domains towards comprehensive policy impact assessments

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Commentary on Coelho et al.: Ecological momentary assessments may be key to the future of cannabis studies

A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study

MENU

CONTACT

Centre de Recherche du CHUM

Téléphone

Courriel